NCT01272856 Study on the Safety of Abatacept in Relapsing Polychondritis Status COMPLETED Phase PHASE1
NCT01221636 Pharmacokinetic Study to Compare the Blood Levels of Low vs High Metal Manufacture of Abatacept Status WITHDRAWN Phase PHASE1
NCT01142726 Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT01116427 A Cooperative Clinical Study of Abatacept in Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT01012492 Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT Status COMPLETED Phase PHASE2
NCT00989235 Substudy - Low Dose of Abatacept in Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT00784459 The Effect of Inhibition of B7-mediated Costimulation on Allergic Airway Inflammation in Mild Atopic Asthmatics Status COMPLETED Phase PHASE2
NCT00774852 Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis Status COMPLETED Phase PHASE2
NCT00767325 A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler Ultrasonography Status COMPLETED Phase PHASE3
NCT00705367 Phase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kg Status COMPLETED Phase PHASE1
NCT00663702 Phase IIIB Switching From Intravenous to Subcutaneous Study Status COMPLETED Phase PHASE3
NCT00558506 Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis Status UNKNOWN Phase PHASE2
NCT00556439 Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis Status COMPLETED Phase PHASE2
NCT00534313 Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis Status TERMINATED Phase PHASE2
NCT00484289 A Phase III Study of Abatacept in Japanese Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE3